KR102598202B1 - 3-에틸비사이클로[3.2.0]헵트-3-엔-6-온의 거울상이성질체의 분리 - Google Patents
3-에틸비사이클로[3.2.0]헵트-3-엔-6-온의 거울상이성질체의 분리 Download PDFInfo
- Publication number
- KR102598202B1 KR102598202B1 KR1020177037104A KR20177037104A KR102598202B1 KR 102598202 B1 KR102598202 B1 KR 102598202B1 KR 1020177037104 A KR1020177037104 A KR 1020177037104A KR 20177037104 A KR20177037104 A KR 20177037104A KR 102598202 B1 KR102598202 B1 KR 102598202B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- formula
- pyrrolidine
- methyl
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
- C07C45/85—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to a chemical modification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B43/00—Formation or introduction of functional groups containing nitrogen
- C07B43/02—Formation or introduction of functional groups containing nitrogen of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B43/00—Formation or introduction of functional groups containing nitrogen
- C07B43/08—Formation or introduction of functional groups containing nitrogen of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
- C07B63/02—Purification; Separation; Stabilisation; Use of additives by treatment giving rise to a chemical modification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/613—Unsaturated compounds containing a keto groups being part of a ring polycyclic
- C07C49/617—Unsaturated compounds containing a keto groups being part of a ring polycyclic a keto group being part of a condensed ring system
- C07C49/623—Unsaturated compounds containing a keto groups being part of a ring polycyclic a keto group being part of a condensed ring system having two rings
- C07C49/627—Unsaturated compounds containing a keto groups being part of a ring polycyclic a keto group being part of a condensed ring system having two rings the condensed ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562167232P | 2015-05-27 | 2015-05-27 | |
| US62/167,232 | 2015-05-27 | ||
| PCT/EP2016/052176 WO2016146299A1 (en) | 2015-05-27 | 2016-02-02 | Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-one |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20180036919A KR20180036919A (ko) | 2018-04-10 |
| KR102598202B1 true KR102598202B1 (ko) | 2023-11-03 |
Family
ID=55404679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020177037104A Active KR102598202B1 (ko) | 2015-05-27 | 2016-02-02 | 3-에틸비사이클로[3.2.0]헵트-3-엔-6-온의 거울상이성질체의 분리 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10150723B2 (https=) |
| EP (1) | EP3303308B1 (https=) |
| JP (1) | JP6775009B2 (https=) |
| KR (1) | KR102598202B1 (https=) |
| CN (1) | CN107667097B (https=) |
| AU (1) | AU2016232606A1 (https=) |
| BR (1) | BR112017025135B1 (https=) |
| CA (1) | CA2986954C (https=) |
| RU (1) | RU2734475C2 (https=) |
| WO (1) | WO2016146299A1 (https=) |
| ZA (1) | ZA201708769B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114264751B (zh) * | 2021-12-28 | 2024-02-27 | 江苏威凯尔医药科技有限公司 | 一种高效液相色谱法分离米洛巴林中间体及其对映异构体的方法 |
| CN115745764B (zh) * | 2022-12-08 | 2024-03-12 | 重庆华森制药股份有限公司 | 一种米洛巴林中间体的制备方法 |
| WO2024134671A1 (en) * | 2022-12-21 | 2024-06-27 | Bhisaj Pharmaceuticals Pvt Ltd | Preparation of 3-ethylbicyclo[3.2.0]hept-3-en-6-one |
| CN116903468B (zh) * | 2023-07-14 | 2024-01-26 | 山东新时代药业有限公司 | 一种米洛巴林中间体的制备方法 |
| CN117886708A (zh) * | 2023-12-05 | 2024-04-16 | 浙江天宇药业股份有限公司 | 一种苯磺酸米洛巴林的合成方法 |
| CN117924061B (zh) * | 2024-01-17 | 2026-03-20 | 北京海步医药科技有限公司 | 一种3-烷基双环[3.2.0]庚-3-烯-6-酮的拆分方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140296569A1 (en) * | 2011-12-15 | 2014-10-02 | Daiichi Sankyo Company, Limited | Optical Resolution Method for Bicyclic Compound Using Asymmetric Catalyst |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU147182A1 (ru) * | 1961-07-18 | 1961-11-30 | Е.С. Жданович | Способ расщеплени синтетического рацемического альфа-окси-бета1-бета-диметил-гамма-бутиролактона |
| EP0074856A3 (en) * | 1981-09-16 | 1984-02-01 | Glaxo Group Limited | Resolution of racemic bicycloheptenones |
| WO2010084798A1 (ja) * | 2009-01-21 | 2010-07-29 | 第一三共株式会社 | 3環性化合物 |
| JP5557292B2 (ja) | 2009-03-26 | 2014-07-23 | 第一三共株式会社 | 二環性γ−アミノ酸誘導体の製造方法 |
| HUE035366T2 (en) | 2011-06-08 | 2018-05-02 | Daiichi Sankyo Co Ltd | A method for the preparation of a bicyclic compound by Claisen rearrangement |
| ES2659162T3 (es) * | 2011-06-08 | 2018-03-14 | Daiichi Sankyo Company, Limited | Procedimiento de producción de compuesto bicíclico a través de una sal de iminio |
| WO2013089189A1 (ja) * | 2011-12-16 | 2013-06-20 | 第一三共株式会社 | ヒドロキシスルホン酸を経由する二環性化合物の光学分割方法 |
| EP2837689B1 (en) * | 2012-04-10 | 2017-02-15 | Daiichi Sankyo Company, Limited | Optical resolution method for bicyclic compound using enzyme |
| JP2013245215A (ja) * | 2012-05-29 | 2013-12-09 | Daiichi Sankyo Co Ltd | 不斉環化反応による光学活性二環性化合物の製造方法 |
| JP6491213B2 (ja) * | 2013-12-18 | 2019-03-27 | ノヴァッセイ エスエー | 疼痛および他の障害の治療のためのガンマ−アミノ酪酸(gaba)類似体 |
-
2016
- 2016-02-02 CN CN201680030795.8A patent/CN107667097B/zh not_active Expired - Fee Related
- 2016-02-02 US US15/576,720 patent/US10150723B2/en not_active Expired - Fee Related
- 2016-02-02 WO PCT/EP2016/052176 patent/WO2016146299A1/en not_active Ceased
- 2016-02-02 EP EP16705440.2A patent/EP3303308B1/en active Active
- 2016-02-02 RU RU2017143338A patent/RU2734475C2/ru active
- 2016-02-02 JP JP2018513721A patent/JP6775009B2/ja active Active
- 2016-02-02 AU AU2016232606A patent/AU2016232606A1/en not_active Abandoned
- 2016-02-02 KR KR1020177037104A patent/KR102598202B1/ko active Active
- 2016-02-02 CA CA2986954A patent/CA2986954C/en active Active
- 2016-02-02 BR BR112017025135-3A patent/BR112017025135B1/pt not_active IP Right Cessation
-
2017
- 2017-12-21 ZA ZA2017/08769A patent/ZA201708769B/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140296569A1 (en) * | 2011-12-15 | 2014-10-02 | Daiichi Sankyo Company, Limited | Optical Resolution Method for Bicyclic Compound Using Asymmetric Catalyst |
Non-Patent Citations (4)
| Title |
|---|
| European Journal of Organic Chemistry, 2011, Vol.5, pp.993-997. |
| Synlett, 2013, Vol.24, pp.2743-2747. |
| Tetrahedron Asymmetry, 2015, Vol.26, pp.102-108. |
| Tetrahedron Letters, 2009, Vol.50, pp.193-197. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107667097A (zh) | 2018-02-06 |
| ZA201708769B (en) | 2019-04-24 |
| JP6775009B2 (ja) | 2020-10-28 |
| CA2986954A1 (en) | 2016-09-22 |
| BR112017025135B1 (pt) | 2023-01-17 |
| CA2986954C (en) | 2023-06-27 |
| EP3303308B1 (en) | 2019-10-09 |
| US20180134643A1 (en) | 2018-05-17 |
| BR112017025135A2 (en) | 2018-08-07 |
| JP2018517768A (ja) | 2018-07-05 |
| AU2016232606A1 (en) | 2017-12-07 |
| RU2734475C2 (ru) | 2020-10-16 |
| US10150723B2 (en) | 2018-12-11 |
| RU2017143338A (ru) | 2019-06-27 |
| KR20180036919A (ko) | 2018-04-10 |
| RU2017143338A3 (https=) | 2019-07-17 |
| WO2016146299A1 (en) | 2016-09-22 |
| EP3303308A1 (en) | 2018-04-11 |
| CN107667097B (zh) | 2021-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102598202B1 (ko) | 3-에틸비사이클로[3.2.0]헵트-3-엔-6-온의 거울상이성질체의 분리 | |
| KR102444718B1 (ko) | 아미노산 유도체의 전구약물 | |
| US9750720B2 (en) | γ-aminobutyric acid (GABA) analogues for the treatment of pain and other disorders | |
| JP7314494B2 (ja) | アミノ酸誘導体のプロドラッグを含有する医薬 | |
| HK1260638B (zh) | 氨基酸衍生物的前药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20171222 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20210129 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20230308 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20230807 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20231031 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20231101 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration |